CAPITELLI SARA B 4
4 · CASI Pharmaceuticals, Inc. · Filed Jul 13, 2018
Insider Transaction Report
Form 4
CAPITELLI SARA B
VP, Finance and PAO
Transactions
- Disposition to Issuer
Common Stock
2018-07-12$7.49/sh−26,600$199,215→ 0 total - Exercise/Conversion
Common Stock
2018-07-12$1.99/sh+35,000$69,475→ 35,000 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-07-12−35,000→ 0 totalExercise: $1.99Exp: 2022-08-15→ Common Stock (35,000 underlying) - Tax Payment
Common Stock
2018-07-12$7.49/sh−8,400$62,910→ 26,600 total
Footnotes (1)
- [F1]The stock options vested as follows: 25% on the date of grant, and the remainder ratably over three years on a monthly basis.